과제정보
연구 과제 주관 기관 : National Research Foundation of Korea
참고문헌
- Krzewski, K. and J. E. Coligan. 2012. Human NK cell lytic granules and regulation of their exocytosis. Front. Immunol. 3: 335.
- Kohl, S., L. S. Loo, F. S. Schmalstieg, and D. C. Anderson. 1986. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo. J. Immunol. 137: 1688-1694.
- Anderson, D. C., F. C. Schmalsteig, M. J. Finegold, B. J. Hughes, R. Rothlein, L. J. Miller, S. Kohl, M. F. Tosi, R. J. Jacobs, and T. C. Waldrop, et al. 1985. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J. Infect. Dis. 152: 668-689. https://doi.org/10.1093/infdis/152.4.668
- Bunting, M., E. S. Harris, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 2002. Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr. Opin. Hematol. 9: 30-35. https://doi.org/10.1097/00062752-200201000-00006
- Inwald, D., E. G. Davies, and N. Klein. 2001. Demystified. adhesion molecule deficiencies. Mol. Pathol. 54: 1-7. https://doi.org/10.1136/mp.54.1.1
- Orange, J. S. 2002. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4: 1545-1558. https://doi.org/10.1016/S1286-4579(02)00038-2
- Parolini, S., C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. D. Ochs, H. Wolf, J. Y. Bonnefoy, R. Biassoni, L. Moretta, L. D. Notarangelo, and A. Moretta. 2000. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192: 337-346. https://doi.org/10.1084/jem.192.3.337
- Bottino, C., M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L. D. Notarangelo, L. Moretta, and A. Moretta. 2001. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194: 235-246. https://doi.org/10.1084/jem.194.3.235
- Ruggeri, L., M. Capanni, E. Urbani, K. Perruccio, W. D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, M. F. Martelli, and A. Velardi. 2002. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 2097-2100. https://doi.org/10.1126/science.1068440
- Igarashi, T., J. Wynberg, R. Srinivasan, B. Becknell, J. P. Jr. McCoy, Y. Takahashi, D. A. Suffredini, W. M. Linehan, M. A. Caligiuri, and R. W. Childs. 2004. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood 104: 170-177. https://doi.org/10.1182/blood-2003-12-4438
- Fischer, L., O. Penack, C. Gentilini, A. Nogai, A. Muessig, E. Thiel, and L. Uharek. 2006. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells. Exp. Hematol. 34: 753-759. https://doi.org/10.1016/j.exphem.2006.02.015
- Billadeau, D. D. and P. J. Leibson. 2002. ITAMs versus ITIMs: striking a balance during cell regulation. J. Clin. Invest. 109: 161-168. https://doi.org/10.1172/JCI0214843
- Vivier, E., J. A. Nunès, and F. Vély. 2004. Natural killer cell signaling pathways. Science 306: 1517-1519. https://doi.org/10.1126/science.1103478
- Long, E. O. 2008. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 224: 70-84. https://doi.org/10.1111/j.1600-065X.2008.00660.x
- Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274. https://doi.org/10.1146/annurev.immunol.23.021704.115526
- Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214: 73-91. https://doi.org/10.1111/j.1600-065X.2006.00457.x
- Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 4: 77-85. https://doi.org/10.1016/S1074-7613(00)80300-3
- Binstadt, B. A., K. M. Brumbaugh, C. J. Dick, A. M. Scharenberg, B. L. Williams, M. Colonna, L. L. Lanier, J. P. Kinet, R. T. Abraham, and P. J. Leibson. 1996. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 5: 629-638. https://doi.org/10.1016/S1074-7613(00)80276-9
- Ting, A. T., L. M. Karnitz, R. A. Schoon, R. T. Abraham, and P. J. Leibson. 1992. Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells. J. Exp. Med. 176: 1751-1755. https://doi.org/10.1084/jem.176.6.1751
- Cella, M., K. Fujikawa, I. Tassi, S. Kim, K. Latinis, S. Nishi, W. Yokoyama, M. Colonna, and W. Swat. 2004. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J. Exp. Med. 200: 817-823. https://doi.org/10.1084/jem.20031847
- Billadeau, D. D., K. M. Brumbaugh, C. J. Dick, R. A. Schoon, X. R. Bustelo, and P. J. Leibson. 1998. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188: 549-559. https://doi.org/10.1084/jem.188.3.549
- Tassi, I., R. Presti, S. Kim, W. M. Yokoyama, S. Gilfillan, and M. Colonna. 2005. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J. Immunol. 175: 749-754. https://doi.org/10.4049/jimmunol.175.2.749
- Upshaw, J. L., R. A. Schoon, C. J. Dick, D. D. Billadeau, and P. J. Leibson. 2005. The isoforms of phospholipase C-gamma are differentially used by distinct human NK activating receptors. J. Immunol. 175: 213-218. https://doi.org/10.4049/jimmunol.175.1.213
- Wu, J., Y. Song, A. B. Bakker, S. Bauer, T. Spies, L. L. Lanier, and J. H. Phillips. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285: 730-732. https://doi.org/10.1126/science.285.5428.730
- Upshaw, J. L., L. N. Arneson, R. A. Schoon, C. J. Dick, D. D. Billadeau, and P. J. Leibson. 2006. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat. Immunol. 7: 524-532. https://doi.org/10.1038/ni1325
- Billadeau, D. D., J. L. Upshaw, R. A. Schoon, C. J. Dick, and P. J. Leibson. 2003. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4: 557-564. https://doi.org/10.1038/ni929
- Zompi, S., J. A. Hamerman, K. Ogasawara, E. Schweighoffer, V. L. Tybulewicz, J. P. Di Santo, L. L. Lanier, and F. Colucci. 2003. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4: 565-572. https://doi.org/10.1038/ni930
- Chiesa, S., M. Mingueneau, N. Fuseri, B. Malissen, D. H. Raulet, M. Malissen, E. Vivier, and E. Tomasello. 2006. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107: 2364-2372. https://doi.org/10.1182/blood-2005-08-3504
- Claus, M., S. Meinke, R. Bhat, and C. Watzl. 2008. Regulation of NK cell activity by 2B4, NTB-A and CRACC. Front. Biosci. 13: 956-965. https://doi.org/10.2741/2735
- Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M. G. Roncarolo, H. Oettgen, J. E. De Vries, G. Aversa, and C. Terhorst. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395: 462-469. https://doi.org/10.1038/26683
- Eissmann, P., L. Beauchamp, J. Wooters, J. C. Tilton, E. O. Long, and C. Watzl. 2005. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105: 4722-4729. https://doi.org/10.1182/blood-2004-09-3796
- Eissmann, P. and C. Watzl. 2006. Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells. J. Immunol. 177: 3170-3177. https://doi.org/10.4049/jimmunol.177.5.3170
- Roncagalli, R., J. E. Taylor, S. Zhang, X. Shi, R. Chen, M. E. Cruz-Munoz, L. Yin, S. Latour, and A. Veillette. 2005. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nat. Immunol. 6: 1002-1010. https://doi.org/10.1038/ni1242
- Chan, B., A. Lanyi, H. K. Song, J. Griesbach, M. Simarro- Grande, F. Poy, D. Howie, J. Sumegi, C. Terhorst, and M. J. Eck. 2003. SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 5: 155-160. https://doi.org/10.1038/ncb920
- Latour, S., R. Roncagalli, R. Chen, M. Bakinowski, X. Shi, P. L. Schwartzberg, D. Davidson, and A. Veillette. 2003. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat. Cell Biol. 5: 149-154. https://doi.org/10.1038/ncb919
- Kim, H. S., A. Das, C. C. Gross, Y. T. Bryceson, and E, O. Long. 2010. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity 32: 175-186. https://doi.org/10.1016/j.immuni.2010.02.004
- Shibuya, K., J. Shirakawa, T. Kameyama, S. Honda, S. Tahara- Hanaoka, A. Miyamoto, M. Onodera, T. Sumida, H. Nakauchi, H. Miyoshi, and A. Shibuya. 2003. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 198: 1829-1839. https://doi.org/10.1084/jem.20030958
- Ralston, K. J., S. L. Hird, X. Zhang, J. L. Scott, B. Jin, R. F. Thorne, M. C. Berndt, A. W. Boyd, and G. F. Burns. 2004. The LFA-1-associated molecule PTA-1 (CD226) on T cells forms a dynamic molecular complex with protein 4.1G and human discs large. J. Biol. Chem. 279: 33816-33828. https://doi.org/10.1074/jbc.M401040200
- Caraux, A., N. Kim, S. E. Bell, S. Zompi, T. Ranson, S. Lesjean-Pottier, M. E. Garcia-Ojeda, M. Turner, and F. Colucci. 2006. Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 107: 994-1002.
- Ombrello, M. J., E. F. Remmers, G. Sun, A. F. Freeman, S. Datta, P. Torabi-Parizi, N. Subramanian, T. D. Bunney, R. W. Baxendale, M. S. Martins, N. Romberg, H. Komarow, I. Aksentijevich, H. S. Kim, J. Ho, G. Cruse, M. Y. Jung, A. M. Gilfillan, D. D. Metcalfe, C. Nelson, M. O'Brien, L. Wisch, K. Stone, D. C. Douek, C. Gandhi, A. A. Wanderer, H. Lee, S. F. Nelson, K. V. Shianna, E. T. Cirulli, D. B. Goldstein, E. O. Long, S. Moir, E. Meffre, S. M. Holland, D. L. Kastner, M. Katan, H. M. Hoffman, and J. D. Milner. 2012. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N. Engl. J. Med. 366: 330-338. https://doi.org/10.1056/NEJMoa1102140
- van Oers, N. S., B. Lowin-Kropf, D. Finlay, K. Connolly, and A. Weiss. 1996. alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 5: 429-436. https://doi.org/10.1016/S1074-7613(00)80499-9
- Mason, L. H., J. Willette-Brown, L. S. Taylor, and D. W. McVicar. 2006. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J. Immunol. 176: 6615-6623. https://doi.org/10.4049/jimmunol.176.11.6615
- Turner, M. and D. D. Billadeau. 2002. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat. Rev. Immunol. 2: 476-486. https://doi.org/10.1038/nri840
- Sylvain, N. R., K. Nguyen, and S. C. Bunnell. 2011. Vav1-mediated scaffolding interactions stabilize SLP-76 microclusters and contribute to antigen-dependent T cell responses. Sci. Signal. 4: ra14.
- Saveliev, A., L. Vanes, O. Ksionda, J. Rapley, S. J. Smerdon, K. Rittinger, and V. L. Tybulewicz. 2009. Function of the nucleotide exchange activity of vav1 in T cell development and activation. Sci. Signal. 2: ra83.
- Tybulewicz, V. L. 2005. Vav-family proteins in T-cell signalling. Curr. Opin. Immunol. 17: 267-274. https://doi.org/10.1016/j.coi.2005.04.003
- Chan, G., T. Hanke, and K. D. Fischer. 2001. Vav-1 regulates NK T cell development and NK cell cytotoxicity. Eur. J. Immunol. 31: 2403-2410. https://doi.org/10.1002/1521-4141(200108)31:8<2403::AID-IMMU2403>3.0.CO;2-O
- Colucci, F., E. Rosmaraki, S. Bregenholt, S. I. Samson, V. Di Bartolo, M. Turner, L. Vanes, V. Tybulewicz, and J. P. Di Santo. 2001. Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. J. Exp. Med. 193: 1413-1424. https://doi.org/10.1084/jem.193.12.1413
- Bryceson, Y. T., H. G. Ljunggren, and E. O. Long. 2009. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 114: 2657-2666. https://doi.org/10.1182/blood-2009-01-201632
- Lanier, L. L., B. Corliss, and J. H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155: 145-154. https://doi.org/10.1111/j.1600-065X.1997.tb00947.x
- Stebbins, C. C., C. Watzl, D. D. Billadeau, P. J. Leibson, D. N. Burshtyn, and E. O. Long. 2003. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 23: 6291-6299. https://doi.org/10.1128/MCB.23.17.6291-6299.2003
- Peterson, M. E. and E. O. Long. 2008. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 29: 578-588. https://doi.org/10.1016/j.immuni.2008.07.014
- Kim, H. S. and E. O. Long. 2012. Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells. Sci. Signal. 5: ra49.
- Koretzky, G. A., F. Abtahian, and M. A. Silverman. 2006. SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat. Rev. Immunol. 6: 67-78. https://doi.org/10.1038/nri1750
- Balagopalan, L., N. P. Coussens, E. Sherman, L. E. Samelson, and C. L. Sommers. 2010. The LAT story: a tale of cooperativity, coordination, and choreography. Cold Spring Harb. Perspect. Biol. 2: a005512.
- Beach, D., R. Gonen, Y. Bogin, I. G. Reischl, and D. Yablonski. 2007. Dual role of SLP-76 in mediating T cell receptor- induced activation of phospholipase C-gamma1. J. Biol. Chem. 282: 2937-2946. https://doi.org/10.1074/jbc.M606697200
- Zhang, W., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, and L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92: 83-92. https://doi.org/10.1016/S0092-8674(00)80901-0
- Finco, T. S., T. Kadlecek, W. Zhang, L. E. Samelson, and A. Weiss. 1998. LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway. Immunity 9: 617-626. https://doi.org/10.1016/S1074-7613(00)80659-7
피인용 문헌
- Beware of NK cells in pre-clinical metastasis models vol.30, pp.7, 2013, https://doi.org/10.1007/s10585-013-9582-9
- De novo assembly and transcriptome characterization: novel insights into the natural resistance mechanisms of Microtus fortis against Schistosoma japonicum vol.15, pp.1, 2012, https://doi.org/10.1186/1471-2164-15-417
- Ras-related C3 Botulinum Toxin Substrate (Rac) and Src Family Kinases (SFK) Are Proximal and Essential for Phosphatidylinositol 3-Kinase (PI3K) Activation in Natural Killer (NK) Cell-mediated Direct C vol.291, pp.13, 2012, https://doi.org/10.1074/jbc.m115.681544
- Enhancing network activation in natural killer cells: predictions from in silico modeling vol.12, pp.5, 2020, https://doi.org/10.1093/intbio/zyaa008